| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Claus A. Andersson last filed a Form 4 in November 2021, as Director at IOBT. Claus A. Andersson's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Claus A. Andersson has 1 Form 4 filing on record in November 2021, as Director at IO Biotech (IOBT), 2021.
The 3 reported transactions were 2 conversions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $1.1M and no sales.
The only open-market purchase was 75,000 shares of IOBT at an average $14.00 on November 9, 2021, about $1.1M. Twelve months later IOBT was down 81%.
Shares as reported in the last Form 4 for each company; the most recent is from November 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2021 | IOBT Io Biotech, Inc. | Director | Buy | 75,000 | $14.00 | $1,050,000.00 | +4.4% | -36.9% | -81.2% |